Former Officer Files to Sell Nearly $800K in Stock, Continuing Recent Trend
OLMA has more than doubled off its 52-week low of $2.86.
Summary
A former officer of Olema Pharmaceuticals has filed to sell an additional $796,796 in company stock, extending a recent trend of significant insider sales.
Key Events · Ownership and Investor Activity · OLMA
-
Former Officer Files to Sell Shares
Shane W. Kovacs, a former officer, has filed a Form 144 to sell 50,000 shares of Olema Pharmaceuticals common stock.
-
Significant Proposed Sale Value
The proposed sale is valued at approximately $796,796.27, representing a notable transaction for an individual.
-
Continuation of Insider Distribution
This filing is part of an ongoing pattern of share sales by Mr. Kovacs, who has sold over $9.25 million in stock over the past three months, indicating a sustained liquidation of holdings.
Analysis · OLMA · Life Sciences
A former officer of Olema Pharmaceuticals, Shane W. Kovacs, has filed a Form 144 indicating an intent to sell 50,000 shares of common stock, valued at approximately $796,796. This filing continues a pattern of significant share dispositions by Mr. Kovacs, who has already sold over $9.25 million worth of shares in the past three months. The ongoing liquidation by a former executive could signal a lack of long-term conviction or a need for personal liquidity, potentially creating an overhang on the stock.
How filings like this one have moved
In the 30 days to Sep 17, 2026, 35.7% of the 1179 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.44%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, OLMA was trading at $15.61 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.2B. The 52-week trading range was $2.86 to $36.26. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.